SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim B who wrote (754)6/15/1998 5:04:00 PM
From: Andrew H  Read Replies (2) of 5402
 
Let me add a several more "bad" reasons.

1. FDA approval will take a minimum of 6 years.

2. Funding to get a product through FDA trials averages over 200M.

3. This company has no partner with deep pockets.

4. Chances are against FDA approval.

5. Even with FDA approval, no product revenues for over 6 years.

6. How many OTCBB stocks do you know that have ever gotten a product through 3 phases of FDA trials to market?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News